Cite
MLA Citation
D. Khanna et al.. “THU0328 SAFETY AND EFFICACY OF SUBCUTANEOUS TOCILIZUMAB IN SYSTEMIC SCLEROSIS: RESULTS FROM THE OPEN-LABEL PERIOD OF THE PHASE 3 FOCUSSCED TRIAL.” Annals of the rheumatic diseases, vol. 79, n.d., p. 394. http://access.bl.uk/ark:/81055/vdc_100144724633.0x000041